Daniel Shevel <br/><br/>
Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Migraine: Should Cochrane Close the Door? 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works